(Q33739104)

English

Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Mitsuyuki Shimizu

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kazuhiko Ogawa

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hideki Sasaki

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yoshiki Uehara

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yumi Otsuka

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hiroyuki Okumura

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Masafumi Kusaka

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Toshio Hasuda

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Taku Yamada

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Seibu Mochizuki

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Current Therapeutic Research

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

707-714

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

A post-marketing observational study to assess the safety of mibefradil in the community in England.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

The physiological determinants and risk correlations of elevated heart rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

21 June 2018

Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

30 October 2018

Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

30 October 2018

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053062

30 October 2018

High heart rate: a risk factor for cardiovascular death in elderly men

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relevance of T-type calcium antagonists: a profile of mibefradil

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CURTHERES.2003.11.004

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

release_yebirtdhxbcmzoxq33riowtyf4

1 reference

https://api.fatcat.wiki/v0/release/yebirtdhxbcmzoxq33riowtyf4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33739104&oldid=2098735356"